HDL Cholesterol

Most people know HDL cholesterol (high-density lipoprotein cholesterol) as the "good cholesterol." And for decades, the message was simple: the higher your HDL, the better. That message is wrong, or at least dangerously incomplete. Large studies following millions of people have now shown that both low and very high HDL cholesterol carry increased risk of death, heart disease, and even cancer. Your HDL number is not just a checkmark on a lab report. It is a window into how well your body is managing one of its most important maintenance tasks.

HDL particles are produced mainly by your liver and intestines. Their primary job is something called reverse cholesterol transport: they pull cholesterol out of your artery walls and shuttle it back to the liver, where it can be broken down and excreted. When this system works well, your arteries stay cleaner. When it falters, cholesterol accumulates in places it does not belong, and the process that leads to heart attacks and strokes accelerates.

The U-Shaped Curve: Why "Higher Is Better" Is Outdated

The biggest shift in HDL science over the past decade is the discovery that the relationship between HDL cholesterol and health is not a straight line. It is U-shaped, meaning risk is elevated at both the low and the high ends. A pooled analysis of 37 studies involving over 3.5 million people found that the sweet spot for lowest death risk was around 54 to 58 mg/dL. Below that, risk climbed. But above it, risk also crept back up: compared to people at 56 mg/dL, those with the highest HDL cholesterol had a 21% higher rate of death from all causes.

A massive study of nearly 16 million Korean adults confirmed the pattern. The optimal range for cardiovascular death was 50 to 79 mg/dL overall, though it varied by age: younger adults had a tighter sweet spot, and the protective ceiling rose somewhat with age. In a separate analysis of the same population, every 39 mg/dL increase in HDL cholesterol above 60 mg/dL was tied to a 39% higher mortality in men and 15% higher mortality in women.

Two large Danish cohorts totaling over 116,000 people put the lowest mortality concentration at 73 mg/dL for men and 93 mg/dL for women. But men with HDL cholesterol above 116 mg/dL had roughly double the death rate of those in the ideal range. For women, those with HDL cholesterol above 135 mg/dL had a 68% higher death rate. The takeaway: extremely high HDL cholesterol is not a badge of superior health. It may signal something else entirely.

Heart Disease Risk

HDL cholesterol's strongest association is with coronary heart disease (the type caused by blockages in the arteries feeding your heart). Each 1 mg/dL increase is linked to about a 2% reduction in risk for men and 3% for women, at least in the low-to-moderate range. People at the 80th percentile of HDL have roughly half the heart disease risk of those at the 20th percentile, based on data from the Framingham Heart Study.

This protective association holds even when LDL cholesterol (the "bad" cholesterol) is aggressively lowered. In a trial of nearly 10,000 patients with stable heart disease taking atorvastatin, HDL cholesterol still predicted future cardiovascular events, even among those who got their LDL below 70 mg/dL. Another trial of 2,193 patients found that those in the highest HDL quarter had a 33% lower risk of death or heart attack compared to the lowest quarter.

There is one major exception. In a large U.S. study of about 24,000 participants, low HDL cholesterol was linked to higher heart disease risk in White individuals (about 22% higher risk) but showed no such association in Black individuals. This suggests that the standard HDL risk thresholds may not apply equally across racial groups, and risk calculators built on predominantly White populations may overestimate the benefit of high HDL in Black populations.

Stroke

The relationship between HDL cholesterol and stroke is more nuanced. Low HDL is associated with higher risk of ischemic stroke (caused by a clot blocking blood flow to the brain): one Korean study found an 11% increase in ischemic stroke risk for people with HDL at or below 40 mg/dL. But the same study found that HDL above 60 mg/dL was associated with a 13% increase in hemorrhagic stroke (caused by bleeding in the brain). This split means that HDL cholesterol does not tell a simple story for stroke risk. The type of stroke matters.

Cancer and Non-Cardiovascular Death

The U-shaped pattern extends beyond the heart. A 22-year Norwegian study of nearly 345,000 people found that those with HDL above 99 mg/dL had a 26% higher rate of cancer death and a 68% higher rate of death from causes other than cardiovascular disease or cancer, compared to the 50 to 59 mg/dL reference group. The pooled analysis of 37 studies placed the optimal HDL range for cancer mortality at 64 to 68 mg/dL.

Reference Ranges

Sex is one of the strongest determinants of HDL cholesterol, with women consistently running higher levels than men. Traditional guidelines defined "low" HDL as below 40 mg/dL for men and below 50 mg/dL for women, while levels above 60 mg/dL were considered protective. More recent population data has refined these thresholds.

These tiers are drawn from published population research, particularly the Korean and Norwegian cohort studies. Your lab may use different cutpoints. Compare your results within the same lab over time for the most meaningful trend. The traditional guideline threshold of 60 mg/dL as universally "protective" is being reconsidered in light of the U-shaped mortality data.

The Quantity vs. Quality Problem

One of the most striking findings in recent HDL research is that raising HDL cholesterol with drugs does not reduce heart attacks or strokes. Trials of niacin, fibrates, and a class of drugs called CETP inhibitors (which block a protein that transfers cholesterol between lipoprotein particles) all raised HDL numbers but failed to prevent cardiovascular events. Genetic studies using a technique called Mendelian randomization (which uses inherited gene variants as natural experiments) reinforce this conclusion: inheriting genes that give you higher HDL cholesterol does not appear to protect you from heart disease.

This means HDL cholesterol is a risk marker, not necessarily a direct cause of protection. Your HDL number reflects the health of your cholesterol transport system, but the number alone does not capture how well your HDL particles actually function. Newer research measures like cholesterol efflux capacity (how efficiently your HDL pulls cholesterol out of cells) and HDL particle number appear to predict cardiovascular risk more accurately than the standard HDL cholesterol measurement. In one trial, HDL particle number was a stronger predictor of residual cardiovascular risk than HDL cholesterol among patients on potent statin therapy.

Tracking Your Trend

HDL cholesterol is one of the most stable lipid measurements you can track. It shows no meaningful daily rhythm (unlike triglycerides, which swing widely after meals), and your level barely changes whether you eat beforehand or not. The biological variation from one test to the next in the same person is about 6 to 7%, meaning a reading of 50 mg/dL could naturally fluctuate between roughly 47 and 53 mg/dL without any real change in your health.

This stability is both a strength and a warning. It means a true shift in your HDL is very likely real, not noise. If your HDL drops by 10 mg/dL or more between tests, something has changed in your body, whether that is weight gain, a new medication, worsening insulin resistance, or the onset of an inflammatory condition. A single reading tells you where you are. A trend across two or three readings, spaced at least 4 to 12 weeks apart, tells you where you are headed.

Get a baseline, then retest in 3 to 6 months if you are making diet or exercise changes. Once stable, annual testing is a reasonable cadence. If you are adjusting medications that affect lipids, retest 4 to 12 weeks after any change. Three measurements taken on separate occasions give you enough precision to establish your personal range with about 8% accuracy.

When Results Can Be Misleading

The biggest threat to an accurate HDL reading is acute illness. During infections, surgery, or any significant inflammatory event, HDL cholesterol can plummet by up to 50% within days. After elective surgery, HDL-related enzymes drop by 24 to 44%, with the lowest point at about 3 to 6 days after the procedure. These changes can persist for days to weeks. Any lipid panel drawn during or shortly after a hospital stay, severe infection, or surgical recovery should be viewed with suspicion. Wait at least 2 to 4 weeks after recovery before testing.

Certain medications shift HDL without reflecting a true change in cardiovascular risk. Thiazide diuretics and beta-blockers (except pindolol) can modestly lower HDL. Anabolic steroids and some progestins can reduce it as well. On the other side, glucocorticoids can raise HDL while simultaneously worsening other metabolic markers. If you are on any of these medications, your HDL number may not fully reflect your underlying cardiovascular protection.

Body weight has a strong inverse relationship with HDL: higher body mass generally means lower HDL. During active weight loss, HDL may temporarily drop further before rebounding once weight stabilizes. This transient dip during caloric restriction does not mean your cardiovascular health is worsening. Seasonal shifts can also play a small role, with HDL tending to run slightly higher in winter and lower in summer.